Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association of Total Oxidant/Antioxidant Capacity and MCP-1 Markers With Abdominal Muscle Thickness and Frailty in Patients With Stage 3-5 Chronic Kidney Disease

NCT07854275 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT07854275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07854275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association of Total Oxidant/Antioxidant Capacity and MCP-1 Markers With Abdominal Muscle Thickness and Frailty in Patients With Stage 3-5 Chronic Kidney Disease
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Completed
Start date
January 15, 2025
Completion date
August 1, 2026
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal muscles/ultrasonography, chronic kidney disease, frailty